YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma-Reference-Cited by-同舟云学术

YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma

Published:2017-06 Issue: Volume:120 Page:242-251
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Kojima Yuki,Hayakawa Fumihiko,Morishita Takanobu,Sugimoto Keiki,Minamikawa Yuka,Iwase Mizuho,Yamamoto Hideyuki,Hirano Daiki,Imoto Naoto,Shimada Kazuyuki,Okada Seiji,Kiyoi Hitoshi

Publisher

Elsevier BV

Subject

Pharmacology

Reference27 articles.

1. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus;Knowles;Blood,1989

2. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement;Walts;Am. J. Clin. Pathol.,1990

3. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study;Simonelli;J. Clin. Oncol.,2003

4. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas;Cesarman;N. Engl. J. Med.,1995

5. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma;Chang;Science,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT6 suppresses colon cancer growth by inducing apoptosis and autophagy through transcriptionally down-regulating Survivin;Mitochondrion;2024-09

2. Licochalcone A: a review of its pharmacology activities and molecular mechanisms;Frontiers in Pharmacology;2024-08-12

3. Crosstalk of cell death pathways implicates heterogeneity among molecular subtypes in colorectal cancer;2023-06-28

4. Autophagy-competent mitochondrial translation elongation factor TUFM inhibits caspase-8-mediated apoptosis;Cell Death & Differentiation;2021-09-12

5. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells;Biochemical Pharmacology;2021-06